Friday, September 20, 2024

AZOOSPERMIA/SEVERE OLIGOZOOSPERMIA �� Y CHROMOSOME (AZFa, AZFb, AZFc MICRODELETIONS) · FRAGMENTS A.

Commercial Kit Change – Results Report Update

Test code: 2674
Mnemonic code: AZF

Effective update from 30/09/2024

Starting on September 30th, and as a result of the change in the CE IVD commercial kit, the way study results are reported will be modified, in compliance with the current scientific guidelines on the matter.

Below is an example of the report:


GENETIC STUDY OF CHROMOSOME Y MICRODELETIONS - REGIONS AZFa, AZFb, AZFc 

Study information and sample
Sample type received       EDTA whole blood
Study                                REGIONS: AZFa, AZFb, AZFc
                                         MIM NUMBER: 415000
                                         INHERITANCE: Y-LINKED

Result

The lack of amplification for sY254 and sY255 markers on chromosome Y suggest the presence of a deletion in AZFc region spanning DAZ gene. The pattern of amplification for extension markers is furthermore consistent with the presence of a complete AZFc deletion (b2/b4).

STS analysed markers (region)

Result

ZFXY (Yp11.2, Xp22.11)

Present

sY14 (Yp11.2)

Present

sY86 (Yq11.221, AZFa)

Present

sY84 (Yq11.221, AZFa)

Present

sY127 (Yq11.223, AZFb)

Present

sY134 (Yq11.223, AZFb)

Present

sY254 (Yq11.23, AZFc, DAZ gene specific)

Absent

sY255 (Yq11.23, AZFc, DAZ gene specific)

Absent

Extension

Result

sY160 (Yq12, heterochromatin)

Present


This result has been confirmed by repeating the analysis on the same sample.

Interpretation
Results are consistent with the presence of a complete removal of the AZFc region on Y chromosome (b2/b4) associated with non-obstructive azoospermia or severe oligozoospermia, being the most likely cause of the patient’s phenotype. 
Complete deletion of AZFc region is associated with a variable phenotype as it is generally compatible with residual spermatogenesis. In case of azoospermia and AZFc region interstitial deletion (as the present one) the probability of obtaining spermatozoa by TESE and conceiving offspring by ICSI is approximately 50%. It is important to assess the possibility of deletion transmission to all male offspring (but none of his female offspring) before performing IVF-ICSI.
Genetic counselling is recommended as well as karyotype analysis for the detection of 45,X0/46,XY mosaicism and testing of the male relatives.
 
Y-chromosomal microdeletions are the second most frequent cause of male infertility, they occur in about 1/4000 men frequency in the general population, significantly increased in infertile men (about 5%). The most frequent deletion type is AZFc region deletion (~80%) followed by AZFa (0.5–4%), AZFb (1–5%) and AZFbc (1–3%) deletion.
 
This report should be evaluated by a specialist in the context of all available clinical and family information in conjunction with other laboratory findings.
 
Test method
DNA extraction followed by fluorescent PCR amplification (CE-IVD method) of the following markers: ZFXY (located on the short arm of chromosomes X and Y), sY14 (located in Yp11.2),  sY86, sY84, sY82, sY83, sY1065 and sY88 (located in AZFa region), sY127, sY134, sY105, sY121, sY1192 and sY153 (located in AZFb region), sY254 and sY255 (specific for DAZ gene in AZFc region), sY160 (located in heterochromatin).
ZFXY amplification as internal PCR control. Detection and fragment analysis is performed by capillary electrophoresis on Applied Biosystems automated sequencer.
 
Test limitations
Sensitivity for detection of clinically relevant deletions in all three AZF regions is approximately >97%. Specificity is >99%. In case clinical suspicion persists, contacting laboratory to evaluate further studies is recommended.
The assay does not exclude point mutations or rearrangements in DAZ gene, or other possible microdeletions or rearrangements in genomic locations other than analysed. 
Karyotype study is recommended in case it has not been performed.
 
References
Lange J et al. (2008) Nucleic Acids Res 36(Database issue): D809-D814.
Wu Q et al. (2011) Asian J Androl. 13(6):877-880.
Krausz C et al. (2014) Andrology. 2(1):5-19
Krausz C et al. (2023) Andrology; 1-18. 

 

   Find the record of the test by clicking here

No comments:

Post a Comment